Literature DB >> 20571605

Biological, psychosocial, therapeutic and quality of life inequalities between HIV-positive men and women - a review from a gender perspective.

Luis Sordo del Castillo1, Isabel Ruiz-Pérez, Antonio Olry de Labry Lima.   

Abstract

The proportion of women infected with HIV worldwide has grown in recent years. From a transmission pattern that was once predominantly homosexual men and through intravenous use of drugs, the current pattern has become, to a large extent, heterosexual. Women are more vulnerable to be infected with HIV due to anatomical and psychosocial differences. In spite of this changing gender trend in the HIV pandemic, biological, psychosocial, therapeutic, and quality of life aspects have not been examined in detail in women. Moreover, this lack of investigation has relevance in terms of vertical transmission of the infection to newborns. Herein, we review gender differences in HIV, identifying from a gender perspective the biological and social factors with a greater influence on vulnerability to infection, and, on the other hand, examining gender differences with respect to the use of services, treatment, survival, and quality of life.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20571605

Source DB:  PubMed          Journal:  AIDS Rev        ISSN: 1139-6121            Impact factor:   2.500


  5 in total

1.  Improved quality of life with immediate versus deferred initiation of antiretroviral therapy in early asymptomatic HIV infection.

Authors:  Alan R Lifson; Birgit Grund; Edward M Gardner; Richard Kaplan; Eileen Denning; Nicole Engen; Catherine L Carey; Fabian Chen; Sounkalo Dao; Eric Florence; Jesus Sanz; Sean Emery
Journal:  AIDS       Date:  2017-04-24       Impact factor: 4.177

2.  Progesterone protects normative anxiety-like responding among ovariectomized female mice that conditionally express the HIV-1 regulatory protein, Tat, in the CNS.

Authors:  Jason J Paris; Jason Fenwick; Jay P McLaughlin
Journal:  Horm Behav       Date:  2014-04-12       Impact factor: 3.587

3.  Combined HIV-1 Tat and oxycodone activate the hypothalamic-pituitary-adrenal and -gonadal axes and promote psychomotor, affective, and cognitive dysfunction in female mice.

Authors:  Mohammed F Salahuddin; Alaa N Qrareya; Fakhri Mahdi; Dejun Jackson; Matthew Foster; Tamara Vujanovic; J Gaston Box; Jason J Paris
Journal:  Horm Behav       Date:  2019-12-13       Impact factor: 3.587

4.  Mobile Text Messaging to Improve Medication Adherence and Viral Load in a Vulnerable Canadian Population Living With Human Immunodeficiency Virus: A Repeated Measures Study.

Authors:  Elizabeth King; Karen Kinvig; Jonathan Steif; Annie Q Qiu; Evelyn J Maan; Arianne Yk Albert; Neora Pick; Ariane Alimenti; Mary H Kestler; Deborah M Money; Richard T Lester; Melanie Caroline Margaret Murray
Journal:  J Med Internet Res       Date:  2017-06-01       Impact factor: 5.428

5.  Prevalence of Physical Health, Mental Health, and Disability Comorbidities among Women Living with HIV in Canada.

Authors:  Emily Heer; Angela Kaida; Nadia O'Brien; Bluma Kleiner; Alie Pierre; Danielle Rouleau; Ann N Burchell; Lashanda Skerritt; Karène Proulx-Boucher; Valerie Nicholson; Mona Loutfy; Alexandra de Pokomandy
Journal:  J Pers Med       Date:  2022-08-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.